IOBT Historical Income Statement
| IOBT Stock | USD 0.89 0.04 4.71% |
Historical analysis of IO Biotech income statement accounts such as Interest Expense of 2.9 K or Selling General Administrative of 13.8 M can show how well IO Biotech performed in making a profits. Evaluating IO Biotech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of IO Biotech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining IO Biotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether IO Biotech is a good buy for the upcoming year.
IOBT |
About IOBT Income Statement Analysis
IO Biotech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to IO Biotech shareholders. The income statement also shows IOBT investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
IO Biotech Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of IO Biotech. It is also known as IO Biotech overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from IO Biotech operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IO Biotech is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from IO Biotech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into IO Biotech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IO Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy IOBT Stock please use our How to Invest in IO Biotech guide.At this time, IO Biotech's Net Interest Income is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 6.5 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 204.2 K in 2024.
IO Biotech income statement Correlations
Click cells to compare fundamentals
IO Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.